Suppression of tumor necrosis factor α-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor κBα complementary DNA into immortalized human salivary gland acinar cells: Prevention of the destruction of the acinar structure in sjogren's syndrome salivary glands

Arthritis and Rheumatism

Volumn 43, Issue 8, 2000, Pages 1756-1767

  Azuma, Masayuki ^a   Aota, Keiko ^a   Tamatani, Tetsuya ^a   Motegi, Katsumi ^a   Yamashita, Tsuyoshi ^a   Harada, Kouji ^a   Hayashi, Yoshio ^a   Sato, Mitsunobu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; COMPLEMENTARY DNA; CYTOKINE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ACINAR CELL; APOPTOSIS; ARTICLE; CELL CLONE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATIC DISEASE; SALIVARY GLAND; SJOEGREN SYNDROME;

BLOTTING, WESTERN; CELL DIVISION; CLONE CELLS; COLLAGEN; CULTURE MEDIA; DNA, COMPLEMENTARY; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PLASMIN; RNA, MESSENGER; SALIVARY GLANDS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033892746     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200008)43:8<1756::AID-ANR12>3.0.CO;2-H     Document Type: Article

References (44)

1. Sjogren's syndrome
2. Labial salivary gland biopsy in Sjogren's syndrome: Assessment as a diagnostic criterion in 362 suspected cases
3. Expression of cytokine genes during development of autoimmune sialadenitis in MRL/1pr mice
4. Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome
5. Dependence of salivary epithelial morphology and branching morphogenesis upon acid mucopolysaccharide protein (proteoglycan) at the epithelial surface
6. 2 production by synovial cells and dermal fibroblasts
7. Interleukin-1β-modulated gene expression in immortalized human chondrocytes
8. Collagenase in Sjogren's syndrome
9. A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: Saliva from patients with Sjogren's syndrome contains increased latent and active gelatinase-B levels
10. Role of cytokines in the destruction of acinar structure in Sjogren's syndrome salivary glands
11. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion
12. Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor α
13. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells
14. The IκB proteins: Multifunctional regulators of Rel/NF-κB transcription factors
15. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: A mechanism for cytoplasmic retention
16. IκBα overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not tumor necrosis factor-α-induced apoptosis
17. Phosphorylation of human IκB-α proteolysis and NF-κB activation in response to diverse stimuli
18. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB
19. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway
20. TGF-β1 inhibits NF-κB activity through induction of IκB-α expression in human salivary gland cells: A possible mechanism of growth suppression by TGF-β1
21. - mutant DNA
22. Secretion of metalloproteinases by stimulated capillary endothelial cells
23. The αvβ6 integrin induces gelatinase B secretion in colon cancer cells
24. Role of tumor necrosis factor receptors in the activation of nuclear factor κB in human histiocytic lymphoma U-937 cells
25. Molecular mechanism of TNFα cytotoxicity: Activation of NF-κB and nuclear translocation
26. Tyrosine phosphorylation of IκBα activates NF-κB without proteolytic degradation of IκB-α
27. Extraction, purification, and analysis of messenger RNA from eukaryotic cells
28. Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenases in colorectal cancer
29. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas
30. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis
31. Tumor necrosis factor-α-induced cell killing and activation of transcription factor NF-κB are uncoupled in L929 cells
32. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
33. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants
34. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival
35. A regulatory role for TRAF1 in antigen-induced apoptosis of T cells
36. TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
37. Function and activation of NF-κB in the immune system
38. The NF-κB and IκB proteins: New discoveries and insights
39. Identification of a serum- and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene
40. Prolonged activation of jun and collagenase genes by tumor necrosis factor-α
41. Matrix metalloproteinase-9 (92-kDa gelatinase/type IV colla- genase) from HT1080 human fibrosarcoma cells: Purification and activation of the precursor, and enzymic properties
42. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate
43. Matrix metalloproteinase-3 (stromelysin) activates the precursor for the human matrix metalloproteinase-9
44. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA